Submitted by Anonymous (not verified) on 19 September 2024 - 14:02
Opinion/decision on a Paediatric investigation plan (PIP): Rozlytrek, Entrectinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0351/2021
Source: